arginine has been researched along with vitamin d 2 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goodman, DS; Kawakami, M | 1 |
| Horowitz, JD; Kelly, DJ; Kennedy, JA; Ngo, DT; Qi, W; Smith, MD; Stafford, I; Sverdlov, AL; Weedon, H; Wuttke, RD; Zhang, Y | 1 |
| Cutrupi, S; Mallamaci, F; Pizzini, P; Thadhani, R; Torino, C; Tripepi, G; Zoccali, C | 1 |
| Cutrupi, S; Mallamaci, F; Pizzini, P; Torino, C; Tripepi, G; Tripepi, R; Zoccali, C | 1 |
| Cutrupi, S; Mallamaci, F; Pizzini, P; Torino, C; Tripepi, G; Tripepi, R; Vilasi, A; Zoccali, C | 1 |
1 review(s) available for arginine and vitamin d 2
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for arginine and vitamin d 2
| Article | Year |
|---|---|
Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.
Topics: Adaptor Proteins, Signal Transducing; Aged; Arginine; Biomarkers; Bone Morphogenetic Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Double-Blind Method; Ergocalciferols; Female; Fibroblast Growth Factor-23; Genetic Markers; Humans; Italy; Lysine; Male; Middle Aged; Receptors, Calcitriol; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Up-Regulation; Vitamins | 2017 |
Vitamin D and methylarginines in chronic kidney disease (CKD).
Topics: Aged; Arginine; Calcium; Cross-Sectional Studies; Double-Blind Method; Ergocalciferols; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Placebos; Vitamin D | 2017 |
Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.
Topics: Aged; Arginine; Ergocalciferols; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Peroxidase; Receptor for Advanced Glycation End Products; Receptors, Calcitriol; Renal Insufficiency, Chronic; S100A12 Protein | 2017 |
4 other study(ies) available for arginine and vitamin d 2
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Effects of protein modification procedures on the interaction between 25-hydroxyvitamin D and the human plasma binding protein for vitamin D and its metabolites.
Topics: 25-Hydroxyvitamin D 2; Arginine; Carrier Proteins; Ergocalciferols; Guanidine; Guanidines; Humans; Lysine; Methylation; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Vitamin D; Vitamin D-Binding Protein | 1981 |
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve; Aortic Valve Stenosis; Arginine; Carrier Proteins; Disease Models, Animal; Disease Progression; Echocardiography; Enzyme Inhibitors; Ergocalciferols; Humans; Male; Rabbits; Ramipril; Vitamins | 2011 |